MD Pediatrix Medical Group, Inc.
Services-Hospitals · NYSE · SEC CIK 893949 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY1.9%
TTM net income YoY-7.5%
TTM EPS YoY-4.2%
Revenue 3-yr CAGR-0.9%
Net income 3-yr CAGR17.1%
Margins
Gross margin—
Operating margin10.9%
Net margin7.7%
FCF margin—
EBITDA margin12.1%
Returns
ROE17.2%
ROA6.9%
ROIC (approx.)13.8%
Asset turnover0.90x
Leverage & solvency
Liabilities / assets60.3%
Debt / equity0.68x
Current ratio1.28x
Interest coverage6.38x
Cash quality & payout
Operating cash flow / net income1.51x
Accruals ratio-3.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $1.91B | $2.01B |
| SG&A expense | $240.79M | $238.44M |
| Operating income | $208.81M | -$68.71M |
| Interest expense | $35.97M | $40.74M |
| Pretax income | $216.43M | -$101.34M |
| Income tax | $51.04M | -$2.27M |
| Net income | $165.39M | -$99.07M |
| EBITDA | $230.64M | -$36.49M |
| EPS (basic) | 1.97 | -1.19 |
| EPS (diluted) | 1.94 | -1.19 |
| Weighted avg. shares (diluted) | 85.27M | 83.33M |
| Balance sheet | ||
| Cash & equivalents | $375.24M | $229.94M |
| Short-term investments | $124.48M | $118.57M |
| Receivables | $229.66M | $259.99M |
| Current assets | $763.51M | $639.61M |
| PP&E, net | $39.18M | $39.17M |
| Goodwill | $1.26B | $1.24B |
| Intangibles | $16.86M | $11.60M |
| Total assets | $2.25B | $2.15B |
| Current liabilities | $458.91M | $434.11M |
| Short-term debt | $26.81M | $20.55M |
| Long-term debt | $570.53M | $597.12M |
| Total debt | $597.34M | $617.66M |
| Total liabilities | $1.38B | $1.39B |
| Shareholders' equity | $865.85M | $764.94M |
| Net debt | $222.10M | $387.72M |
| Shares outstanding | 82.98M | 85.87M |
| Cash flow statement | ||
| Operating cash flow | $271.09M | $206.57M |
| Investing cash flow | -$18.30M | -$35.41M |
| Financing cash flow | -$107.49M | -$14.48M |
| Depreciation & amortization | $21.83M | $32.23M |
| Stock-based compensation | $18.05M | $11.87M |
| Share buybacks | $86.68M | $1.70M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.